News ‘It’s Remarkable’: Deep Tech Ventures Summit Showcases Innovation in the Midwest Nearly 350 attendees, 23 speakers, and 22 startups came together to explore various topics across the quantum, data science and AI, cleantech, and life sciences space at the Deep Tech...
News Edward L. Kaplan, ’71, New Venture Challenge Winner Simple Mills Acquired by Flower Foods for $795 Million The $795 million acquisition represents one of the largest exits by a Polsky Center startup Founded in 2012, Simple Mills offers nutrient-dense crackers, cookies, snack bars, and baking mixes made...
News Record $2.267 Million Awarded at 2025 Edward L. Kaplan, ’71, New Venture Challenge, B2B SaaS Company Takes First Rayni, a B2B SaaS company, has won first place in the 29th Annual Edward L. Kaplan, ’71, New Venture Challenge (NVC), during which a record-breaking more than $2.2 million was...
News How to Become a Successful CEO The following article was written by Steven Kaplan, the Neubauer Family Distinguished Service Professor of Entrepreneurship & Finance at Chicago Booth School of Business and Kessenich E.P. Faculty Director at...
News The Coasts Don’t Own Innovation. They Just Own the Capital. Innovation is no longer confined to a few coastal cities. We know that well in the Midwest. Across the region, our universities, research labs, and entrepreneurs are launching companies in...
Technology Small Molecule Inhibitor Boosting The Efficacy Of Therapeutic Ionizing Radiation Radiotherapy and immunotherapy are used to treat many cancer types, yet only 50% and 20% of patients respond, respectively. Resistance to therapy presents a large problem. N6-methyladenosine (m6A) modification is…
Technology Small Molecule Inhibitors Targeting RNA Modifying Enzymes to Modulate Drug Response and Overcome Drug Resistance DNA hypomethylating agents have been widely used to treat various hematologic and non-hematologic malignancies. However, accumulating evidence has demonstrated that DNA methylation status does not correlate with clinical response to…
Technology Antibody Blockade Method To Augment Hemolysis For Treatment Of Sepsis Sepsis is a systemic response to infection and remains a leading cause of death in intensive care units worldwide while our understanding of the pathogenesis of sepsis across most tissues…
Technology Flexible, AI-Enabled Wearables for Precision Medicine This technology enables on-body AI data analysis of data from skin-like wearable electronics for achieving human-integrated/mimetic intelligent systems. The Unmet Need: Data processing for precision medicine Precision medicine, the future…
News Rattan L. Khosa Took a Risk to Build Something New and Now Helps NVC Founders Do the Same Rattan L. Khosa speaks to the students at SeedCon 2025. As part of the NVC@30 celebration, Rattan L. Khosa, ’79, reflected on his entrepreneurial journey, his connection to Booth, and...
News From NVC Finalist to Global Investor, Koichiro Nakamura Continues to Support the Program That Helped Shape His Path As part of the NVC@30 celebration, Nakamura reflected on his journey from Booth student and two-time NVC finalist to Sozo Ventures cofounder, Polsky Council member, NVC judge, and longtime supporter...
Program Our Process and Advisory Committee Our Process The George Shultz Innovation Fund invests in promising startups from an ecosystem that includes the University of Chicago, Argonne National Laboratory, Fermilab, and the Marine Biological Laboratory. The...
